Curoverse, Inc. » Blog Curoverse corporate website Tue, 14 Apr 2015 18:52:58 +0000 en-US hourly 1 http://wordpress.org/?v=355 Welcome to the Curoverse Public Beta /blog/welcome-to-the-curoverse-public-beta/ /blog/welcome-to-the-curoverse-public-beta/#comments Tue, 14 Apr 2015 06:04:54 +0000 /?p=219 Today, we officially announced the launch of the Curoverse Cloud public beta program and the Curoverse Cluster pilot program. These are two great ways to use the Arvados open source platform for managing and processing genomic and other biomedical data.

Curoverse Cloud provides Arvados through a Software-as-a-Service (SaaS) solution running in the cloud. It only takes a moment to . With your account, you can upload up to 1 TB of data and use 100 hours of compute per month. (If you need more storage or compute capacity for your trial, feel free to ) You also have access to public data sets, including data from Harvard PGP and 1000 Genomes, so you can try the system even without uploading data. You’ll find a variety of pipelines that have already been implemented, and it’s easy to create your own pipelines. It will only take you a few minutes to sign up and run your first pipeline.

Curoverse Cluster supports running Arvados in your own data center with your own servers or on hyperconverged appliances we provide or on your own hardware. If you’re considering an on-premise deployment of Arvados, this pilot program is a great way to get started. It’s fully supported, and we’ll work with you every step of the way from planning to deployment to operation to evaluation. The Curoverse Cluster pilot program is already being rolled out at major institutions around the world.

Arvados is free and open source software. We don’t use proprietary software in our services. We simply make it easy for you to use Arvados in the cloud or in your datacenter. You can get involved with the open source project at , and you can download the code from . If you want to run a development version on your desktop, there is an option for that using Docker.

If you sign up for the beta, you’re guaranteed six months of free usage. We plan to start charging for Curoverse Cloud in the second half of 2015. We expect to offer highly competitive pricing including per pipeline run and predictable monthly subscriptions. For on-premise deployments, we’ll offer the Curoverse Operations Subscription, which is similar to Red Hat subscriptions. If you want a price quote before you try the beta, please

We look forward to hearing your feedback on the beta. Please don’t hesitate to suggest ideas for new features! Also, you can join our development team on if you have any questions. You can also contact us directly at support@curoverse.com.

]]> /blog/welcome-to-the-curoverse-public-beta/feed/ 0 Curoverse at Bioinformatics Open Source Conference 2014! /blog/curoverse-at-bioinformatics-open-source-conference-2014/ /blog/curoverse-at-bioinformatics-open-source-conference-2014/#comments Tue, 15 Jul 2014 16:01:08 +0000 /?p=177 Curoverse proudly sponsored the at , which drew over 50 attendees from the open source bioinformatics community. Several members of our science and engineering teams attended and answered questions from the open source community. Attendees also received complimentary Curoverse beta accounts!

Our engineering team really enjoys answering your technical questions. If you’d like to chat with them, you can find them .

Additionally, we’re proud that a BOSC talk submitted by Brett Smith, one of our engineers, was accepted for the conference. You can watch it here!

[Image at left by , used under CC BY-SA 2.o license.]

]]> /blog/curoverse-at-bioinformatics-open-source-conference-2014/feed/ 0 Alexander Wait Zaranek on “Will bioinformatics scale?” /blog/alexander-wait-zaranek-on-will-bioinformatics-scale/ /blog/alexander-wait-zaranek-on-will-bioinformatics-scale/#comments Thu, 30 Jan 2014 20:20:02 +0000 /?p=153 This week, Dr. Alexander (Sasha) Wait Zaranek, Curoverse’s chief scientist, spoke on a panel at the entitled, “Will bioinformatics scale?” Sasha was joined by Somalee Datta, Director of the Bioinformatics Core at the , and Jonathan Hirsch, Founder and President of .

Dr. Datta’s comments focused on the challenges of data and analysis provenance — simply the difficulty of being able to know where a piece of data or code came from, and how it was produced. She also pointed to the struggles to make data and computation interoperate across institutions, or even across labs within the same institution.

Dr. Zaranek predicted a move from legacy High Performance Computing environments to private clouds based on free & open source software in combination with off-the-shelf hardware. Other industries, such as web and financial services made this transition many years ago, saving billions of dollars and achieving scale much more rapidly. For biomedical, doing so would require moving to a single open bioinformatics platform not owned by a single company or institution.

In Q&A, one audience member asked how to create standardization across the industry, the way the did for the semantic web. Dr. Zaranek compared bodies such as the recently-launched Global Alliance for Genomics and Health to the W3C, as two industry-wide bodies that are each focused on crafting sustainable industry strategies. (Curoverse is a partner in the Global Alliance for Genomics and Health.)

Dr. Alexander (Sasha) Wait Zaranek, Curoverse and Harvard Personal Genome Project; Dr. Somalee Datta, Stanford Bioinformatics Core; Jonathan Hirsch, Syapse

 

 

[Image at left by , used under CC BY-SA 2.o license.]

]]> /blog/alexander-wait-zaranek-on-will-bioinformatics-scale/feed/ 0 The Arvados HealthFoo Ignite Talk /blog/the-arvados-healthfoo-ignite-talk/ /blog/the-arvados-healthfoo-ignite-talk/#comments Fri, 20 Dec 2013 04:56:27 +0000 /?p=110 HealthFoo, which took place on December 7th and 8th, featured an array of speakers from the healthcare and biomedical world, including our own scientific director, Alexander Wait Zaranek, also known as Sasha. Watch as Sasha explains the specific needs created by exabyte-scale biomedical data, all in five minutes.

Learn more about the Arvados open source project at .

]]> /blog/the-arvados-healthfoo-ignite-talk/feed/ 0 Seed Funding Announcement Press Coverage /blog/seed-funding-announcement-press-coverage/ /blog/seed-funding-announcement-press-coverage/#comments Thu, 19 Dec 2013 21:46:38 +0000 /?p=100 We were delighted to see the press on our announcements yesterday regarding our funding, new name, open source project, and private beta. There were a number of great articles that really tell our story. Here are just a few:

By Ben Fidler, Xconomy

By Uduak Grace Thomas, GenomeWeb Bioinform

By Aaron Krol, Bio-IT World

By Nick Paul Taylor, FierceBiotechIT

By Glyn Moody, Computerworld UK

By Brian Gormley, VentureWire

By Christina Farr, VentureBeat

By Lauren Landry, BostInno

Photo credit:

]]> /blog/seed-funding-announcement-press-coverage/feed/ 0 Welcome to Curoverse /blog/welcome-to-curoverse/ /blog/welcome-to-curoverse/#comments Wed, 18 Dec 2013 04:58:51 +0000 /?p=80 For those of you who have been following our journey, you know that until today we’ve been called Clinical Future. Now we’re changing our name to Curoverse.

Today, we’re also announcing our seed financing round, officially announcing the Arvados open source project, and beginning the private beta for our platform-as-a-service. Of course, there is more to come in 2014 when we start launching products. Take a look at the press release for the full announcement.

We changed our name from Clinical Future to Curoverse because we found that our old name was confusing. (People thought we were a clinic.) As the universe of genomic and biomedical data expands, we believe that the name Curoverse better reflects that we provide the computational storage infrastructure researchers and clinicians will use to usher in a new era of precision medicine.

Today is also the official announcement of the Arvados free and open source software initiative. Many of you have become familiar with  Arvados since its informal launch in April. When you visit the Arvados site, you’ll see new content and branding. You’ll also meet our new mascot, Dax!

We plan to support Arvados through a variety of products. The first is a platform-as-a-service (PaaS), and today we’ve begun the private beta program for that service. If you’d like to try Arvados you can apply on the home page.

We look forward to working with you more in the coming year.

]]> /blog/welcome-to-curoverse/feed/ 0